1. What data in particular will be shared?
   Response - All of the individual participant data collected during the trial, after de-identification.
   


2. What additional supporting information will be shared?
   Response -  Study Protocol
   Response - Informed Consent Form
   Response - Clinical Study Report
   
   
3. Who will be able to view these files?
   Response - Researchers who provide a methodologically sound proposal.
   


4. For what types of analyses will this data be available?
   Response - To achieve aims in the approved proposal.
   


5. By what mechanism will data be made available?
   Response - Proposals should be directed to [mailtogirishj@gmail.com].
   


6. For how long will this data be available start date provided 23-12-2022 and end date provided 23-11-2028?
   Response - Beginning 3 months and ending 5 years following article publication.
   


7. Any URL or additional information regarding plan/policy for sharing IPD? 
   Additional Information - Nil

Sepsis associated acute kidney injury is a syndrome of acute loss of renal function, defined by the simultaneous presence of both Sepsis and renal dysfunction as per KDIGO criteria. Severe sepsis and septic shock are the main causes of acute kidney injury (AKI) in the intensive care unit (ICU). The treatment of AKI is supportive. No generally accepted guidelines for indication or optimal timing for initiation of renal replacement therapy (RRT) exist. Apart from life-threatening indications, the initiation of RRT is mainly based on clinical judgment.The long-term mortality of hospital survivors with AKI remains increased for several years after critical illness. Risk and outcomes for sepsis associated AKI in adult patients admitted to ICU has not been systematically evaluated. The objectives of this study is to assess the association of risk factors and outcome of ICU patients with sepsis associated AKI.

All consecutive adults admitted to ICU with suspected infection, along with SOFA score >6 or acute increase in SOFA score by >2 or culture positive sepsis will be enrolled. We will use KDIGO criteria to define AKI during ICU stay. The enrolled patients will be followed till ICU/Hospital discharge, ICU or hospital mortality, resolution of AKI, death or survival at day 90 from entry, and for long term outcome of the development of chronic kidney disease. We will collect data on multiple variables and risk factors.